Navigation Links
NIDA's Dr. Volkow joins President Clinton on Clinton Foundation's prescription drug abuse panel
Date:5/3/2013

Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will join President Bill Clinton, New York dignitaries, and college students from New York University for a panel discussion on prescription drug abuse. The panel will address prescription drug abuse, particularly among 18 26 year olds, and how the Clinton Foundation's Clinton Health Matters Initiative can work with others to contribute to solutions in New York and nationwide.

WHAT: Prescription Drug Abuse: A Forum with President Clinton, Commissioner Ray Kelly, NYU President John Sexton, and Dr. Nora Volkow
Hosted by the Clinton Foundation's Clinton Health Matters Initiative

WHEN: Monday, May 6, 2013
10:30 a.m. EST
(Press must check in by 9:45 a.m. EST)

WHERE: New York University School of Law
Vanderbilt Hall, Greenberg Lounge
40 Washington Square South
New York, N.Y. 10012

Media interested in attending must RSVP by May 5 to press@clintonfoundation.org.

WHO: Featured Speakers

President Bill Clinton
Founder, Clinton Foundation
42nd President of the United States

Raymond W. Kelly
Police Commissioner, City of New York

John Sexton, Ph.D., J.D.
President, New York University

Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse


'/>"/>

Contact: NIDA Press Team
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
Source:Eurekalert

Page: 1

Related medicine news :

1. Avenidas Village Hosts Second Annual Financial Conference
2. Avenidas Village Introduces ER INFO Flash Drives
3. Avenidas Rose Kleiner Center to Host "How To" Workshop for Family Caregivers
4. IU Simon Cancer Center joins WellPoint in developing health care solutions
5. ACP joins Million Hearts to help save lives from preventable heart attacks and strokes
6. Gum disease joins hot flashes and PMS associated with womens hormones
7. Advertising Industry Veteran Pat McCrossan Joins Mangos
8. Rush joins elite group of institutions with accredited research programs
9. American Academy of Family Physicians joins AmericanEHR Partners
10. Test-Med Joins Forces with Mollen to Expand its Service Offerings to its Customers
11. Beige Fat Joins Brown Fat as Potential Weight-Loss Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which ... nutrients from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... the body recognizes its raw form (unlike the synthetically made options that are on ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... an agile ecosystem and domain expertise for sponsors and CROs to speed ... trial supply management (RTSM) software platform. Bioclinica AGILE RTSM provides ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... and collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 ... experience for education and business. , Mirroring360 Pro enables educators, business professionals and ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment can ... also decrease overall productivity and performance in the workplace. The goal of Clearview Resolution ... last few weeks of April, Clearview Resolution Services will be shutting down the office ...
(Date:4/25/2017)... ... , ... The doctors at Wall Centre Dental are now expanding their practice ... sedation to receive dental care. The doctors offer three treatment options to put victims ... oral surgery, at their dental office in Vancouver. Wall Centre Dental is currently welcoming ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/19/2017)... , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton ... Edward Wright , Chief Executive Officer of the Company is scheduled ... CFO, Richard Bear and the Chairman of the Board, ... ...
Breaking Medicine Technology: